Vitronectin, a serum and extracellular matrix protein, is present in vivo in two different conformations: a native form, which does not bind heparin, and a heparin-binding conformer, which results from interactions of native vitronectin with either the thrombin-antithrombin III complex or the terminal complement complex, C5b-9. We found that vitronectin stimulates the activity of the growth regulatory peptide, TGF-beta, in the conditioned media of bovine aortic endothelial cells as a result of increased production of latent TGF-beta. This effect is specific for the denatured, heparin-binding, form of vitronectin, since native vitronectin has no effect on the production of latent TGF-beta by those cells. Stimulation is time and concentration-dependent, but is independent of protease activity. Stimulation is dependent on the presence of cells, since there was no increase in TGF-beta activity observed when vitronectin was added to the conditioned media after removal from cells. Furthermore, incubation of recombinant latent TGF-beta with vitronectin in a cell-free system does not result in increased TGF-beta activity. Assays of total TGF-beta levels in heat-treated conditioned media showed that vitronectin treatment elevates the levels of total TGF-beta in the conditioned media. These results were further confirmed by western blot analysis of the conditioned media with antibodies specific for latent TGF-beta. These data suggest that vitronectin regulates expression and/or secretion of TGF-beta by bovine aortic endothelial cells. This cellular response to the heparin-binding form of vitronectin seems to be mediated by alpha v beta 3 integrins.(ABSTRACT TRUNCATED AT 250 WORDS)

REFERENCES

Akama
T.
,
Yamada
K. M.
,
Seno
N.
,
Matsumoto
I.
,
Kono
I.
,
Kashiwagi
H.
,
Funaki
T.
,
Hayashi
M.
(
1986
).
Immunological characterization of human vitronectin and its binding to glycosaminoglycans.
J. Biochem
100
,
1343
1351
Antonelli-Orlidge
A.
,
Saunders
K. B.
,
Smith
S. R.
,
D'Amore
P. A.
(
1989
).
An activated form of transforming growth factoris produced by cocultures of endothelial cells and pericytes.
Proc. Nat. Acad. Sci. USA
86
,
4544
4548
Assoian
R. K.
,
Komoryia
A.
,
Meyers
C. A.
,
Miller
D. M.
,
Sporn
M. B.
(
1983
).
Transforming growth factor-beta in human platelets.
J. Biol. Chem
258
,
7155
7160
Bascom
C. C.
,
Wolfshohl
J. R.
,
Coffey
R. J.
Jr.
,
Madisen
L.
,
Webb
N. R.
,
Purchio
A. R.
,
Derynck
R.
,
Moses
H. L.
(
1989
).
Complex regulation of transforming growth factor1, 2and3mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors 1and2.
Mol. Cell. Biol
9
,
5508
5515
Bittorf
S. V.
,
Williams
E. C.
,
Mosher
D. F.
(
1993
).
Alteration of vitronectin. Characterization of changes induced by treatment with urea.
J. Biol. Chem
268
,
24838
24846
Brown
P. D.
,
Wakefield
L. M.
,
Levinson
A. D.
,
Sporn
M. B.
(
1990
).
Physiochemical activation of recombinant latent transforming growth factor betas 1, 2, and 3.
Growth Factors
3
,
35
43
Cadroy
Y.
,
Houghten
R. A.
,
Hanson
S. R.
(
1989
).
RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo.
J. Clin. Invest
84
,
939
944
Dallas
S. L.
,
Park-Snyder
S.
,
Myiazono
K.
,
Twardzik
D.
,
Mundy
G. R.
,
Bonewald
L. F.
(
1994
).
Characterization and autoregulation of latent transforming growth factor-(TGF-) complexes in osteoblast-like cell lines.
J. Biol. Chem
269
,
6815
6822
de Boer
H. C.
,
Preissner
K. T.
,
Bouma
B. N.
,
de Groot
P. G.
(
1992
).
Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin.
J. Biol. Chem
267
,
2264
2268
Felding-Habermann
B.
,
Cheresh
D. A.
(
1993
).
Vitronectin and its receptors.
Curr. Opin. Cell Biol
5
,
864
868
Gaido
K. W.
,
Maness
S. C.
,
Leonard
L. S.
,
Greele
W. F.
(
1992
).
2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-and- 2expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control.
J. Biol. Chem
267
,
24591
24595
Gentry
L. E.
,
Lioubin
M. N.
,
Purchio
A. F.
,
Marquardt
(
1988
).
Molecular events in the processing of type I pre-pro-transforming growth factor beta to the mature polypeptide.
Mol. Cell Biol
8
,
4162
4168
Glick
A. B.
,
Flanders
K. C.
,
Danielpour
D.
,
Yuspa
S. H.
,
Sporn
M. B.
(
1989
).
Retinoic acid induces transforming growth factor-2 in cultured keratinocytes and mouse epidermis.
Cell Regul
1
,
87
97
Grinnell
F.
,
Ho
C. H.
,
Alumets
J.
,
Dahlback
B.
(
1989
).
Immunohistochemical demonstration of age-related deposition of vitronectin (S-protein of complement) and terminal complement complex on dermal elastic fibers.
J. Invest. Dermatol
92
,
727
733
Hayman
E. C.
,
Pierchbacher
M. D.
,
Ohgre
Y.
,
Ruoslahti
E.
(
1983
).
Serum spreading factor (vitronectin) is present at the cell surface and in tissues.
Proc. Nat. Acad. Sci. USA
80
,
4003
4007
Heimark
R. L.
,
Twardzik
D. R.
,
Schwarz
S. M.
(
1986
).
Inhibition of endothelial cell regeneration by type-beta transforming growth factor from platelets.
Science
233
,
1078
1080
Hogasen
K.
,
Mollnes
T. E.
,
Harboe
M.
(
1992
).
Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex.
J. Biol. Chem
267
,
23076
23082
Holmes
R.
(
1967
).
Preparation from human serum of an1protein which induces the immediate growth of unadapted cells in vitro.
J. Cell Biol
32
,
297
308
Ikeda
T.
,
Lioubin
M. N.
,
Marquardt
H.
(
1987
).
Human transforming growth factor type2: production by a prostatic adenocarcinima cell line, purification and initial characterization.
Biochemistry
26
,
2406
2410
Izumi
M.
,
Yamada
K. M.
,
Hayashi
M.
(
1989
).
Vitronectin exists in two structurally and functionally distinct forms in human placenta.
Biochim. Biophys. Acta
990
,
101
108
Kerl
J. H.
,
Wakefield
L. M.
,
Roberts
A. B.
,
Jakowlew
S.
,
Alvarez-Mon
M.
,
Derynck
R.
,
Sporn
M. B.
,
Fauci
A. S.
(
1986
).
Production of transforming growth factorby human T lymphocytes and its potential role in the regulation of T cell growth.
J. Exp. Med
163
,
1037
1050
Keski-Oja
J.
,
Leof
E. B.
,
Lyons
R. M.
,
Coffey
R. J.
Jr.
,
Moses
H. L.
(
1987
).
Transforming growth factors and control of neoplastic cell growth.
J. Cell Biochem
33
,
95
107
Kim
S.-J.
,
Jeang
K.-T.
,
Glick
A. B.
,
Sporn
M. B.
,
Roberts
A. B.
(
1989
).
Promoter sequences of the human transforming growth factor-1autoinduction.
J. Biol. Chem
264
,
7041
7045
Kim
S.-J.
,
Glick
A. B.
,
Sporn
M. B.
,
Roberts
A. B.
(
1989
).
Characterization of the promoter region of the human transforming growth factor-1gene.
J. Biol. Chem
264
,
402
408
Kim
S.-J.
,
Angel
P.
,
Lafyatis
R.
,
Hattori
K.
,
Kim
K. Y.
,
Sporn
M. B.
,
Karin
M.
,
Roberts
A. B.
(
1990
).
Autoinduction of transforming growth factor1 is mediated by the AP-1 complex.
Mol. Cell. Biol
10
,
1492
1497
Kim
S.-J.
,
Park
K.
,
Rudkin
B. B.
,
Dey
B. R.
,
Sporn
M. B.
,
Roberts
A. B.
(
1994
).
Nerve growth factor induces transcription of transforming growth factor-1through a specific promoter element in PC12 cells.
J. Biol. Chem
269
,
3739
3744
Kornberg
L. J.
,
Earp
H. S.
,
Turner
C. E.
,
Prockop
C.
,
Juliano
R. L.
(
1991
).
Signal transduction by integrins: increased protein tyrosine phosphorilation caused by clustering of1 integrins.
Proc. Nat. Acad. Sci. USA
88
,
8392
8396
Kost
C.
,
Stuber
W.
,
Ehrlich
H. J.
,
Pannekock
H.
,
Preissner
K. T.
(
1992
).
Mapping of binding sites for heparin, plasminogen activator inhibitor-1 and plasminogen to vitronectin's heparin binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
J. Biol. Chem
267
,
12098
12105
Kovacina
K. S.
,
Steele-Perkins
G.
,
Purchio
A. F.
,
Lioubin
M.
,
Miyazono
K.
,
Heldin
C.-H.
,
Roth
R. A.
(
1989
).
Interactions of recombinant and platelet transforming growth factor-1precursor with the insulin-like growth factor/ mannose-6-phosphate receptor.
Biochem. Biophys. Res. Commun
160
,
393
403
Kubota
K.
,
Katayama
S.
,
Matsuda
M.
,
Hayashi
M.
(
1988
).
Three types of vitronectin in human blood.
Cell Struct. Funct
13
,
123
128
Lyons
R. M.
,
Keski-Oja
J.
,
Moses
H. L.
(
1988
).
Proteolytic activation of latent transforming growth factor-from fibroblast-conditioned medium.
J. Cell Biol
106
,
1659
1665
Massague
J.
(
1990
).
The transforming growth factor family.
Annu. Rev. Cell Biol
6
,
597
641
McPherson
J.
,
Sage
H.
,
Bornstein
P.
(
1981
).
Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture: apparent identity with platelet thrombospondin.
J. Biol. Chem
256
,
11330
11336
Mosher
D. F.
,
Doyle
M. J.
,
Jaffe
E. A.
(
1982
).
Synthesis and secretion of thrombospondin by cultured endothelial cells.
J. Cell Biol
93
,
343
348
Murphy-Ullrich
J. E.
,
Schultz-Cherry
S.
,
Hook
M.
(
1992
).
Transforming growth factor-complexes with thrombospondin.
Mol. Biol. Cell
3
,
181
188
Naski
M. C.
,
Lawrence
D. A.
,
Mosher
D. F.
,
Podor
T. J.
,
Ginsburg
D.
(
1993
).
Kinetics of inactivation of-thrombin by plasminogen activator inhibitor-1. Comparison of the effects of native and urea-treated forms of vitronectin.
J. Biol. Chem
268
,
12367
12372
Panetti
T. S.
,
McKeown-Longo
P. J.
(
1993
).
Receptor-mediated endocytosis of vitronectin is regulated by its conformational state.
J. Biol. Chem
268
,
11988
11993
Panetti
T. S.
,
McKeown-Longo
P. J.
(
1993
).
Thev 5integrin receptor regulates receptor-mediated endocytosis of vitronectin.
J. Biol. Chem
268
,
11492
11495
Pircher
R.
,
Jullien
P.
,
Lawrence
D. A.
(
1986
).
-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex.
Biochem. Biophys. Res. Commun
136
,
30
37
Preissner
K. T.
,
Holzhuter
S.
,
Justus
C.
,
Muller-Berghaus
G.
(
1989
).
Identification and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1.
Blood
74
,
1989
1996
Raugi
G. J.
,
Olerud
J. E.
,
Gown
A. M.
(
1987
).
Thrombospondin in early human wound tissue.
J. Invest. Dermatol
89
,
551
554
Roberts
A. B.
,
Anzano
M. A.
,
Wakefield
L. M.
,
Roche
N. S.
,
Sporn
M. B.
(
1985
).
Type-transforming growth factor: a bifunctional regulator of cellular growth.
Proc. Nat. Acad. Sci. USA
82
,
119
123
Roberts
A. B.
,
Sporn
M. B.
(
1988
).
Transforming growth factor.
Advan. Cancer Res
51
,
107
145
Sato
Y.
,
Rifkin
D. B.
(
1989
).
Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-1-like molecule by plasmin during co-culture.
J. Cell Biol
109
,
309
315
Schultz-Cherry
S.
,
Murphy-Ullrich
J. E.
(
1993
).
Thrombospondin causes activation of latent transforming growth factor-secreted by endothelial cells by a novel mechanism.
J. Cell Biol
122
,
923
932
Schultz-Cherry
S.
,
Ribeiro
S.
,
Gentry
L.
,
Murphy-Ullrich
J. E.
(
1994
).
Thrombospondin binds and activates the small and large forms of latent transforming growth factor-in a chemically defined system.
J. Biol. Chem
269
,
26775
26782
Seiffert
D.
,
Keeton
M.
,
Eguchi
Y.
,
Sawdey
M.
,
Loskutoff
D. J.
(
1991
).
Detection of vitronectin mRNA in tissues and cells of the mouse.
Proc. Nat. Acad. Sci. USA
88
,
9402
9406
Seiffert
D.
,
Crain
K.
,
Wagner
N. V.
,
Loskutoff
D. J.
(
1994
).
Vitronectin gene expression in vivo. Evidence for extrahepatic synthesis and acute phase regulation.
J. Biol. Chem
269
,
19836
19842
Shaffer
M. C.
,
Foley
T. P.
,
Barnes
D. W.
(
1984
).
Quantitation of spreading factor in human biologic fluids.
J. Lab. Clin. Med
103
,
783
791
Sporn
M. B.
,
Roberts
A. B.
,
Wakefield
L. M.
,
Assoian
R. K.
(
1986
).
Transforming growth factor-: biological function and chemical structure.
Science
233
,
532
534
Stockmann
A.
,
Hess
S.
,
Declerck
P.
,
Timpl
R.
,
Preissner
K. T.
(
1993
).
Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein.
J. Biol. Chem
268
,
22874
22882
Tomasini
B. R.
,
Mosher
D. F.
(
1988
).
Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and non-covalently complexed with thrombin-antithrombin III or treated with urea.
Blood
72
,
903
912
Tomasini
B. R.
,
Owen
M. C.
,
Fenton
J. W.
II
,
Mosher
D. F.
(
1989
).
Conformational lability of vitronectin: induction of an antigenic change by-thrombin-serpin complexes and by proteolytically modified thrombin.
Biochemistry
28
,
7617
7623
Van Obberghen-Schilling
E.
,
Roche
N. S.
,
Flanders
K. C.
,
Sporn
M. B.
,
Roberts
A. B.
(
1988
).
Transforming growth factor-1 positively regulates its own expression in normal and transformed cells.
J. Biol. Chem
263
,
7741
7746
Yorochko
A. D.
,
Liu
D. Y.
,
Eierman
D.
,
Haskill
S.
(
1992
).
Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction.
Proc. Nat. Acad. Sci. USA
89
,
9034
9038
This content is only available via PDF.